MedPath

asal microbe modulation to manage chronic inflammatory conditions of the nose and paranasal sinuses

Not Applicable
Conditions
Health Condition 1: J328- Other chronic sinusitis
Registration Number
CTRI/2022/02/040464
Lead Sponsor
AIIMS Bhubaneswar
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Adults (more than 18 years);

Diagnosis of CRS based on American Academy of Otolaryngology-Head Neck Surgery guidelines, refractory CRS,

Atrophic Rhinitis based on clinical examination

Exclusion Criteria

Pregnancy, comorbidities that preclude travel for follow up, declining to be included in the study, a SNOT22 score of less than 10, LM score of less than 4 in cases of CRS.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Microbiome profile of patients with chronic inflammatory diseases of the nose and PNS <br/ ><br>2. Improved quality of life of patients with chronic inflammation of the nose and PNS (in CRS and Atrophic Rhinitis)Timepoint: 3 years
Secondary Outcome Measures
NameTimeMethod
1. Normal nasal microbiome profile across age and gender <br/ ><br>2.The CT scan picture of the patients with the disease and following intervention <br/ ><br>3.The histopathological changes following intervention in Chronic inflammatory diseases <br/ ><br>4.To assess the change in the microbiome in these patients following intervention <br/ ><br>Timepoint: 3 years
© Copyright 2025. All Rights Reserved by MedPath